Comment on

• The loss of retinoblastoma gene in association with c-myc and transforming growth factor-beta 1 gene expression in human bladder cancer.

  Kubota Y, Miyamoto H, Noguchi S, Shuin T, Kitamura H, Xu HJ, Hu SX, Benedict WF. Kubota Y, et al. J Urol. 1995 Aug;154(2 Pt 1):371-4. doi: 10.1097/00005392-199508000-00009. J Urol. 1995. PMID: 7609100
• Transurethral ultrasonographic assessment of bladder carcinoma: its value and limitation.

  Koraitim M, Kamal B, Metwalli N, Zaky Y. Koraitim M, et al. J Urol. 1995 Aug;154(2 Pt 1):375-8. doi: 10.1097/00005392-199508000-00010. J Urol. 1995. PMID: 7609101 Clinical Trial.
• Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer.

  Sarosdy MF, deVere White RW, Soloway MS, Sheinfeld J, Hudson MA, Schellhammer PF, Jarowenko MV, Adams G, Blumenstein BA. Sarosdy MF, et al. J Urol. 1995 Aug;154(2 Pt 1):379-83; discussion 383-4. doi: 10.1097/00005392-199508000-00013. J Urol. 1995. PMID: 7609102 Clinical Trial.